IL17A and colorectal cancer: Furthermore, a study revealed that IL-17A induces mitochondrial dysfunction in colorectal cancer cells by activating the ROS/NOD-like receptor protein 3/caspase-4/gasdermin D pathway, stimulating intracellular ROS production and promoting tumor cell pyroptosis (Feng et al., 2023).